Cargando…
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy
Despite passing the pandemic phase of the COVID-19, researchers are still investigating various drugs. Previous evidence suggests that blocking the calcium channels may be a suitable treatment option. Ca(2+) is required to enhance the fusion process of Severe acute respiratory syndrome coronavirus 2...
Autores principales: | Fani, Mona, Moossavi, Maryam, Bakhshi, Hasan, Jahrodi, Abozar Nasiri, Khazdair, Mohammad Reza, Zardast, Amir Hossein, Ghafari, Shokouh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494978/ https://www.ncbi.nlm.nih.gov/pubmed/37700758 http://dx.doi.org/10.2217/fvl-2022-0203 |
Ejemplares similares
-
Targeting the Channel Activity of Viroporins
por: To, Janet, et al.
Publicado: (2016) -
The Rotavirus NSP4 Viroporin Domain is a Calcium-conducting Ion Channel
por: Pham, Thieng, et al.
Publicado: (2017) -
Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020) -
Viroporins
por: Hyser, Joseph M.
Publicado: (2015) -
Death by viroporin
por: Jones, Susan
Publicado: (2007)